BridgeBio Pharma, Inc. (BBIO)
68.21
+1.82
(+2.74%)
USD |
NASDAQ |
Oct 19, 13:19
BridgeBio Pharma Cash from Operations (Annual) : -445.91M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -445.91M |
| December 31, 2024 | -520.73M |
| December 31, 2023 | -527.72M |
| December 31, 2022 | -419.49M |
| December 31, 2021 | -497.93M |
| Date | Value |
|---|---|
| December 31, 2020 | -399.71M |
| December 31, 2019 | -253.59M |
| December 31, 2018 | -136.64M |
| December 31, 2017 | -40.49M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Pfizer Inc. | 11.70B |
| Ionis Pharmaceuticals, Inc. | -268.58M |
| Vertex Pharmaceuticals, Inc. | 3.631B |
| ACADIA Pharmaceuticals, Inc. | 109.84M |